GR

Govinda Rajulu Karna

Active Director Director DIN 01636998
DIN 01636998 First appointment Jul 2006 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Jul 2006
Shareholding value •••• Premium profile

About Govinda Rajulu Karna

Data last updated:

Govinda Rajulu Karna is a Director at Glocell Chemical Industries Private Limited (since 2010) and Managing Director at Rohit Biotech Private Limited (since 2019). The companies operate in Chemicals and Materials, Food And Beverages and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹2.22 Cr; the largest is Glocell Chemical Industries Private Limited at ₹1.40 Cr (FY 2023). Earlier, Govinda Rajulu Karna was a Director at Savvy Spechems Private Limited (2006–2024) and Director at Cephachem Laboratories Private Limited (2020–2023) and 1 more.

DIN 01636998
Primary Designation Director
Industry Chemicals and Materials
First Appointment 05 Jul 2006
Oldest Company Age 16 yrs
Largest company Glocell Chemical Industries Private Limited · ₹1.40 Cr (FY 2023)
Combined revenue ₹2.22 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Oct 20102010₹1.40 Cr (FY 2023)Active
Rohit Biotech Private Limited U24304TG2019PTC133347
Managing Director12 Jun 20192019₹82.2 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Savvy Spechems Private Limited U24239TG2004PTC044051
Director05 Jul 20062004₹4.27 Cr (FY 2024)Active
Director05 Feb 20202020₹6.03 Cr (FY 2025)Active
Director29 Nov 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Glocell Chemical Industries Private Limited
Sangra Biotech Lifesciences Private Limited
Rohit Biotech Private Limited
Savvy Spechems Private Limited
Premium access

Shareholding and investment profile for Govinda Rajulu Karna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Govinda Rajulu Karna

Govinda Rajulu Karna currently holds 2 directorships: Glocell Chemical Industries Private Limited (Director, since 05 Oct 2010, revenue ₹1.40 Cr (FY 2023)); Rohit Biotech Private Limited (Managing Director, since 12 Jun 2019, revenue ₹82.2 Lakh (FY 2024)).

Govinda Rajulu Karna was first appointed on 05 Jul 2006 as Director at Savvy Spechems Private Limited. The most recent appointment on record is 05 Feb 2020 at Cephachem Laboratories Private Limited.

The 2 current companies of Govinda Rajulu Karna that report revenue have a combined latest revenue of ₹2.22 Cr: Glocell Chemical Industries Private Limited ₹1.40 Cr (FY 2023); Rohit Biotech Private Limited ₹82.2 Lakh (FY 2024).

Govinda Rajulu Karna held 3 earlier board appointments: Savvy Spechems Private Limited (Director, 05 Jul 2006 to 21 Sep 2024); Cephachem Laboratories Private Limited (Director, 05 Feb 2020 to 31 Mar 2023); Sangra Biotech Lifesciences Private Limited (Director, from 29 Nov 2017).

The current boards of Govinda Rajulu Karna's companies include Agarwal Niranjan (Glocell Chemical Industries Private Limited), Laxmaiah Chilukala (Glocell Chemical Industries Private Limited), Sirka Mohan Jagan (Glocell Chemical Industries Private Limited), Bala Venkata Sri Sai Rohit Karna (Rohit Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available